By Susanne Posel
theintelhub.com
The Food and Drug Administration has approved an ingestible digital senor that can track physical health with the assertion that patients are not taking their medication regularly and need a tracking device inside their body to assist them in their medical care.
The mainstream medical industry has a term for this new type of spying: individualized medicine.
Proteus Digital Health (PDH) released the Ingestion Event Marker (IEM) which was first approved in Europe. George Savage, co-founder and chief medical officer at PDH claims that this ushers in a new era of digital medicine that “shifts the paradigm.”
The IEM, as small as a grain of sand, can be embedded in a pill, and ingested to monitor the patient and their bodily health. The device will collect measurements such as heart rate, body position and activity.
The IEM sends a signal to your smartphone; which then transmits the data to your doctor. Actual real time data about your biological make-up can be uploaded wirelessly.
theintelhub.com
The Food and Drug Administration has approved an ingestible digital senor that can track physical health with the assertion that patients are not taking their medication regularly and need a tracking device inside their body to assist them in their medical care.
The mainstream medical industry has a term for this new type of spying: individualized medicine.
Proteus Digital Health (PDH) released the Ingestion Event Marker (IEM) which was first approved in Europe. George Savage, co-founder and chief medical officer at PDH claims that this ushers in a new era of digital medicine that “shifts the paradigm.”
The IEM, as small as a grain of sand, can be embedded in a pill, and ingested to monitor the patient and their bodily health. The device will collect measurements such as heart rate, body position and activity.
The IEM sends a signal to your smartphone; which then transmits the data to your doctor. Actual real time data about your biological make-up can be uploaded wirelessly.
Eric Topol, geneticist and cardiologist, is a professor of genomics at the globalist funded Scripps Research Institute, happily says: “The FDA validation represents a major milestone in digital medicine.
Directly digitizing pills, for the first time, in conjunction with our wireless infrastructure, may prove to be the new standard for influencing medication adherence and significantly aid chronic disease management.”
The transhumanists at 2045 Initiative support the IEM. They are a group of Russian scientists who are working toward the “realization of the possibility of a radical extension of human life by means of cybernetic technology” with the directed point of blending humanity with a “new culture” based on science.
Read the full article at - http://theintelhub.com/2012/08/04/individualized-medicine-fda-approved-ingestible-microchip-tracking-device/
